scispace - formally typeset
Open AccessJournal ArticleDOI

The proximal origin of SARS-CoV-2.

Reads0
Chats0
TLDR
It is shown that SARS-CoV-2 is not a laboratory construct or a purposefully manipulated virus, and scenarios by which they could have arisen are discussed.
Abstract
SARS-CoV-2 is the seventh coronavirus known to infect humans; SARSCoV, MERS-CoV and SARS-CoV-2 can cause severe disease, whereas HKU1, NL63, OC43 and 229E are associated with mild symptoms6. Here we review what can be deduced about the origin of SARS-CoV-2 from comparative analysis of genomic data. We offer a perspective on the notable features of the SARS-CoV-2 genome and discuss scenarios by which they could have arisen. Our analyses clearly show that SARS-CoV-2 is not a laboratory construct or a purposefully manipulated virus.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

COVID-19 and future pandemics: a global systems approach and relevance to SDGs.

TL;DR: In this paper, a global view using a systems science approach is used to recognize the close interactions between health of animals, humans and the environment. But some determinants in the model are poorly addressed by SDGs such as population pressures, cultural factors, corporate interests and globalization.
Journal ArticleDOI

COVID-19: molecular targets, drug repurposing and new avenues for drug discovery

TL;DR: A critical view of ongoing drug repurposing efforts for COVID-19 is presented as well as discussing opportunities for development of new treatments based on current knowledge of the mechanism of infection and potential targets within.
Book ChapterDOI

SARS-CoV-2 in animals: From potential hosts to animal models

TL;DR: In this article, the authors provide an update on studies describing permissive and resistant animal species, using a scoring system based on viral genome detection subsequent to SARS-CoV-2 inoculation, seroconversion, the development of clinical signs and transmission to conspecifics or humans.
Journal ArticleDOI

The biggest mystery: what it will take to trace the coronavirus source.

David Cyranoski
- 05 Jun 2020 - 
TL;DR: SARS-CoV-2 came from an animal but finding which one will be tricky, as will laying to rest speculation of a lab escape, will prove tricky and time consuming.
Journal ArticleDOI

Apical Takotsubo Cardiomyopathy in a COVID-19 Patient Presenting with Stroke: A Case Report and Pathophysiologic Insights

TL;DR: A 72-year-old woman with multiple cardiovascular risk factors and COVI 19 pneumonia who presented with acute ischemic stroke is presented, believed to be the first case of apical variant of takotsubo cardiomyopathy in a COVID-19 report.
References
More filters
Journal ArticleDOI

A pneumonia outbreak associated with a new coronavirus of probable bat origin

TL;DR: Identification and characterization of a new coronavirus (2019-nCoV), which caused an epidemic of acute respiratory syndrome in humans in Wuhan, China, and it is shown that this virus belongs to the species of SARSr-CoV, indicates that the virus is related to a bat coronav virus.
Journal ArticleDOI

A new coronavirus associated with human respiratory disease in China.

TL;DR: Phylogenetic and metagenomic analyses of the complete viral genome of a new coronavirus from the family Coronaviridae reveal that the virus is closely related to a group of SARS-like coronaviruses found in bats in China.
Journal ArticleDOI

An interactive web-based dashboard to track COVID-19 in real time.

TL;DR: The outbreak of the 2019 novel coronavirus disease (COVID-19) has induced a considerable degree of fear, emotional stress and anxiety among individuals around the world.
Journal ArticleDOI

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.

TL;DR: The authors show that this protein binds at least 10 times more tightly than the corresponding spike protein of severe acute respiratory syndrome (SARS)–CoV to their common host cell receptor, and test several published SARS-CoV RBD-specific monoclonal antibodies found that they do not have appreciable binding to 2019-nCoV S, suggesting that antibody cross-reactivity may be limited between the two RBDs.
Related Papers (5)